The Potential of a New Population Screening: Preventing Osteoporotic Fractures
DOI:
https://doi.org/10.20344/amp.23360Keywords:
Osteoporotic Fractures/prevention & controlAbstract
n/a.
Downloads
References
Quintal C, Antunes M. Picturing prevalence and inequalities in cancer screening attendance to population-based programs in Portugal. Acta Med Port. 2023;36:577-87.
Direção-Geral da Saúde. Avaliação e monitorização dos rastreios oncológicos de base populacional - Relatório 2024. Lisboa: DGS; 2024
Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, et al. European Code Against Cancer, 4th edition: cancer screening. Cancer Epidemiol. 2015;39:S139-52.
Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16:82.
Marques A, Lourenço Ó, da Silva JA, Portuguese Working Group for the Study of the Burden of Hip Fractures in Portugal. The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality. Osteoporos Int. 2015;26:2623-30.
Merlijn T, Swart KM, van der Horst HE, Netelenbos JC, Elders PJ. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis. Osteoporos Int. 2020;31:251-7.
Rodrigues A, Canhão H, Marques A, Ambrósio C, Borges J, Coelho P, et al. Portuguese recommendations for the prevention, diagnosis and management of primary osteoporosis: 2018 update. Acta Reumatol Port. 2018;43:10-31.
Ferreira RJ, Marques A, Prieto-Moreno R, Silva T, Pinho A, Pimentel G, et al. Implementing systematic screening of fracture risk and osteoporosis treatment in Portugal: a feasibility study protocol. ARP Rheumatol. 2025;4:69-71.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Acta Médica Portuguesa

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

